156 related articles for article (PubMed ID: 20682616)
1. Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis?
Toms TE; Panoulas VF; Douglas KM; Nightingale P; Smith JP; Griffiths H; Sattar N; Symmons DP; Kitas GD
Angiology; 2011 Feb; 62(2):167-75. PubMed ID: 20682616
[TBL] [Abstract][Full Text] [Related]
2. Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis.
Toms TE; Panoulas VF; Smith JP; Douglas KM; Metsios GS; Stavropoulos-Kalinoglou A; Kitas GD
Ann Rheum Dis; 2011 Jun; 70(6):1025-32. PubMed ID: 21398331
[TBL] [Abstract][Full Text] [Related]
3. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
[TBL] [Abstract][Full Text] [Related]
4. The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better.
Peters MJ; Voskuyl AE; Sattar N; Dijkmans BA; Smulders YM; Nurmohamed MT
Int J Clin Pract; 2010 Sep; 64(10):1440-3. PubMed ID: 20716150
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients.
Morris SJ; Wasko MC; Antohe JL; Sartorius JA; Kirchner HL; Dancea S; Bili A
Arthritis Care Res (Hoboken); 2011 Apr; 63(4):530-4. PubMed ID: 21452265
[TBL] [Abstract][Full Text] [Related]
6. Dyslipoproteinemia in patients with active rheumatoid arthritis: effects of disease activity, sex, and menopausal status on lipid profiles.
Yoo WH
J Rheumatol; 2004 Sep; 31(9):1746-53. PubMed ID: 15338494
[TBL] [Abstract][Full Text] [Related]
7. High HDL-cholesterol in women with rheumatoid arthritis on low-dose glucocorticoid therapy.
García-Gómez C; Nolla JM; Valverde J; Narváez J; Corbella E; Pintó X
Eur J Clin Invest; 2008 Sep; 38(9):686-92. PubMed ID: 18837746
[TBL] [Abstract][Full Text] [Related]
8. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
9. Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment.
Steiner G; Urowitz MB
Semin Arthritis Rheum; 2009 Apr; 38(5):372-81. PubMed ID: 18395771
[TBL] [Abstract][Full Text] [Related]
10. Atherogenic lipid profiles in rheumatoid arthritis.
White D; Fayez S; Doube A
N Z Med J; 2006 Aug; 119(1240):U2125. PubMed ID: 16924276
[TBL] [Abstract][Full Text] [Related]
11. Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions.
Choy E; Sattar N
Ann Rheum Dis; 2009 Apr; 68(4):460-9. PubMed ID: 19286905
[TBL] [Abstract][Full Text] [Related]
12. Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey.
Choi HK; Seeger JD
J Rheumatol; 2005 Dec; 32(12):2311-6. PubMed ID: 16331755
[TBL] [Abstract][Full Text] [Related]
13. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications.
Kerr G; Aujero M; Richards J; Sayles H; Davis L; Cannon G; Caplan L; Michaud K; Mikuls T
Arthritis Care Res (Hoboken); 2014 Nov; 66(11):1619-26. PubMed ID: 24692402
[TBL] [Abstract][Full Text] [Related]
14. Conversion towards an atherogenic lipid profile in rheumatoid arthritis patients during long-term infliximab therapy.
Dahlqvist SR; Engstrand S; Berglin E; Johnson O
Scand J Rheumatol; 2006; 35(2):107-11. PubMed ID: 16641043
[TBL] [Abstract][Full Text] [Related]
15. Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis.
Kiortsis DN; Mavridis AK; Filippatos TD; Vasakos S; Nikas SN; Drosos AA
J Rheumatol; 2006 May; 33(5):921-3. PubMed ID: 16541480
[TBL] [Abstract][Full Text] [Related]
16. Modest but sustained increase of serum high density lipoprotein cholesterol levels in patients with inflammatory arthritides treated with infliximab.
Spanakis E; Sidiropoulos P; Papadakis J; Ganotakis E; Katsikas G; Karvounaris S; Bizaki A; Kritikos H; Boumpas DT
J Rheumatol; 2006 Dec; 33(12):2440-6. PubMed ID: 17014005
[TBL] [Abstract][Full Text] [Related]
17. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
Nordestgaard BG; Zacho J
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
[TBL] [Abstract][Full Text] [Related]
18. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis.
Liao KP; Playford MP; Frits M; Coblyn JS; Iannaccone C; Weinblatt ME; Shadick NS; Mehta NN
J Am Heart Assoc; 2015 Jan; 4(2):. PubMed ID: 25637346
[TBL] [Abstract][Full Text] [Related]
19. Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.
Vis M; Nurmohamed MT; Wolbink G; Voskuyl AE; de Koning M; van de Stadt R; Twisk JW; Dijkmans BA; Lems WF
J Rheumatol; 2005 Feb; 32(2):252-5. PubMed ID: 15693084
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk factors in Chilean patients with rheumatoid arthritis.
Cisternas M; Gutiérrez MA; Klaassen J; Acosta AM; Jacobelli S
J Rheumatol; 2002 Aug; 29(8):1619-22. PubMed ID: 12180719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
